发明名称 GLYCINE TRANSPORTER INHIBITOR
摘要 The present invention provides a compound represented by the following formula or a pharmaceutically acceptable salt of the compound or a hydrate of the compound or the salt, which is useful for the prevention or treatment of diseases such as schizophrenia, Alzheimer's disease, cognitive dysfunction, dementia, anxiety disorders (generalized anxiety disorder, panic disorder, obsessive compulsive disorder, social anxiety disorder, post-traumatic stress disorder, particular phobias, acute stress disorder, etc.), depression, drug abuse, convulsion, tremor, and sleep disorders, based on glycine uptake inhibitory effect.
申请公布号 WO2008018639(A3) 申请公布日期 2008.04.03
申请号 WO2007JP65988 申请日期 2007.08.10
申请人 TAISHO PHARMACEUTICAL CO., LTD.;SEKIGUCHI, YOSHINORI;OKUBO, TAKETOSHI;SHIBATA, TSUYOSHI;ABE, KUMI;YAMAMOTO, SHUJI;KASHIWA, SHUHEI 发明人 SEKIGUCHI, YOSHINORI;OKUBO, TAKETOSHI;SHIBATA, TSUYOSHI;ABE, KUMI;YAMAMOTO, SHUJI;KASHIWA, SHUHEI
分类号 C07D401/10;C07D401/14;C07D403/10;C07D403/14;C07D405/10;C07D409/14;C07D413/10;C07D417/14 主分类号 C07D401/10
代理机构 代理人
主权项
地址